Soleno Therapeutics, Inc.Soleno Therapeutics, Inc.Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc.

No trades
See on Supercharts

Price target

67.000.00 0.00%
The 7 analysts offering 1 year price forecasts for SLNO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to SLNO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

SLNO EPS for the last quarter is −0.59 USD despite the estimation of −0.37 USD. In the next quarter EPS is expected to reach −0.49 USD. Track more of Soleno Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Soleno Therapeutics, Inc. revenue is expected to reach 0 USD. Check out Soleno Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SLNO price target is 67.00 USD with a max estimate of 93.00 USD and a min estimate of 59.00 USD. Check if this forecast comes true in a year, meanwhile watch Soleno Therapeutics, Inc. stock price chart and keep track of the current situation with SLNO news and stock market news.
We've gathered opinions of 7 analysts rating SLNO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.